Monday Morning Update 9/15/25
Top News
The FDA grants clearance for the upgraded cardiac imaging platform of precision medicine vendor Tempus AI, sending the company’s shares up 14% on Thursday to reach a market cap of $15…
Continue Reading
Tag: AI risks
We need to act fast to close the NHS AI safety gap
Yvette Khozam, ePMA lead pharmacist at West London NHS Trust (Credit: YSK Designs)
Current safety standards can’t keep up with AI, writes Yvette Khozam, electronic prescribing and medicines administration (ePMA) lead pharmacist at West…
Continue Reading